CAS: 124379-29-9; (S)-4-(3,4-Dichlorophenyl)-3,4-Dihydronaphthalen-1(2H)-One

结构式图片

欧盟法规

统一分类与标签REACH注册ECHA物质ECHA物质REACH预注册废弃物危险特性清单

上下游产品

(4R)-(3,4-Dichlorophenyl)benzenebutanoic acid 1,1-dimethylethyl ester (4R)-4-(3,4-dichlorophenyl)-4-phenylbutanoic acid (1R,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-ol (4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-ylidene)methylamine (1R,4S)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphthalen-1-ol (S)-N-(4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-ylidene)methanamine trans-(1R,4S)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine Sertraline

合成工艺路线路线简述

    3,4-二氯碘苯置于盐酸,氯磺酸体系中,用 二氯甲烷 用作溶剂,化学反应 23.5H,反应生成4-(3,4-二氯苯)-3,4-二氢-2H-萘-1-酮
    参考文献:A Catalytic Enantioselective Synthetic Route To The Important Antidepressant Sertraline
    标题:A Catalytic Enantioselective Synthetic Route To The Important Antidepressant Sertraline
    摘要:An Efficient Catalytic Enantioselective Synthesis Of The Important Antidepressant Sertraline Is Described (Scheme I).
    Doi:10.1016/s0040-4039(00)73503-9

    海关参考信息

    专利信息


    专利号:EP-3800178-A1
    优先权日:2019-10-01
    标题:Preparation of enamide intermediate for the synthesis of dasotraline
    发明人:BALLETTE ROBERTO; DOBARRO RODRÃ?GUEZ ALICIA
    权利人:MOEHS IBERICA SL
    摘要:The present invention relates to a process for the preparation of N -(( S )-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1-yl)acetamide, which is a suitable intermediate for the synthesis of dasotraline or a pharmaceutically acceptable salt thereof, as well as to a process for the preparation of dasotraline or a pharmaceutically acceptable salt thereof using said N -(( S )-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1-yl)acetamide intermediate.

    专利号:WO-2016088138-A1
    优先权日:2014-12-01
    标题 :Diphenyloxiranes, process for preparation thereof, and its use in an enantioselective synthesis of (+)-sertraline
    发明人:SURYAVANSHI GURUNATH MALLAPPA; SUDALAI ARUMUGAM; KAMBLE ROHIT BALKRISHNA
    权利人:COUNCIL SCIENT IND RES
    摘要:The present invention discloses substituted diphenyloxiranes and process for synthesis thereof. The present invention also provides a process for production of enantiomerically pure anti-3,3' -diphenylmethyloxirane and anti-3,3'- diphenylpropan- 1,2-diol from racemic anti-3,3' -diphenylmethyloxirane using hydrolytic kinetic resolution. Further it provides a process for preparation of enantioselective (+)- Sertraline from anti-3,3' -diphenylpropan-1,2-diol.

    专利号:US-2001044142-A1
    优先权日:2000-04-28
    标题:Microbial reductase useful for the stereoselective reduction of a racemic tetralone
    发明人:BROWN MARIA S; FEDECHKO RONALD W; WONG JOHN W
    摘要:The present invention relates to novel compositions of matter comprising an enzyme activity capable of carrying out the following stereoselective reduction of a racemic tetralone: n n n The chiral tetralone can be used in the synthesis of sertraline, well known to be useful, for example, as an antidepressant and anorectic agent, and in the treatment of chemical dependencies, anxiety-related disorders, premature ejaculation, cancer and post-myocardial infarction.

    专利号:US-6589777-B1
    优先权日:1998-10-29
    标题:Stereoselective microbial reduction of a racemic tetralone
    发明人:MORSE BROOK K; TRUESDELL SUSAN J; WONG JOHN W
    权利人:PFIZER
    摘要:The present invention relates to processes for carrying out the following stereoselective microbial reduction of a racemic tetralone: n which comprises: contacting a compound of formula (I) with a microorganism, or an enzyme reduction system capable of accomplishing the subject reduction comprising an enzyme derived from said microorganism and a co-factor for said enzyme, and incubating the resulting mixture under conditions sufficient to yield the (4R) tetralol of formula (II) and to leave substantially unreacted the (4S) tetralone of formula (V) or “chiral tetralone.â€? The chiral tetralone can be used in the synthesis of sertraline. The subject process further optionally comprises the separation of the (4S) tetralone of formula (V) from the (4R) tetralol of formula (II). The (4R) tetralol can be recycled to produce the compound of formula (I) and the subject process repeated to result in even more of the desired (4S) tetralone of formula (V).

    专利号:WO-0130742-A1
    优先权日:1998-11-23
    标题:Improved synthesis of racemic sertraline

    专利号:US-5750794-A
    优先权日:1993-11-30
    标 题:Process for preparing chiral tetralone
    发明人:QUALLICH GEORGE J
    权利人:PFIZER
    摘要:A process for preparing the chiral (4S)-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone is disclosed wherein racemic 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone is asymmetrically reduced by contacting the racemic tetralone with an asymmetric reagent to produce a mixture of cis and trans alcohols, separating the cis from the trans alcohols, and oxidizing the (4S) enantiomer of the resulting cis and trans alcohols. Also disclosed are novel intermediates used in the synthesis of the above chiral tetralone.
    广州万仟医药科技有限公司
    小微企业
    注册号: 91440101068197284B法定代表人:朱成林
    注册资本:100万元人民币类型:有限责任公司(自然人投资或控股)
    成立日期:2013-05-23登记机关:广州市番禺区市场监督管理局
    注册地址: 广州市番禺区番禺大道北555号番禺节能科技园内天安科技产业大厦1座401
    食用农产品零售;食用农产品初加工;非食用农产品初加工;信息技术咨询服务;数据处理服务;数据处理和存储支持服务;大数据服务;互联网数据服务;人工智能应用软件开发;软件开发;供应链管理服务;品牌管理;专业设计服务;广告设计、代理;地产中草药(不含中药饮片)购销;海洋生物活性物质提取、纯化、合成技术研发;中药提取物生产;专用化学产品销售(不含危险化学品);食品进出口;室内卫生杀虫剂销售;饲料原料销售;技术进出口;货物进出口;软件销售;中草药收购;食品添加剂销售;饲料添加剂销售;合成材料销售;互联网销售(除销售需要许可的商品);眼镜销售(不含隐形眼镜);个人卫生用品销售;初级农产品收购;卫生用品和一次性使用医疗用品销售;消毒剂销售(不含危险化学品);日用口罩(非医用)销售;医用口罩批发;医护人员防护用品批发;化妆品批发;特殊医学用途配方食品销售;保健食品(预包装)销售;宠物食品及用品批发;销售代理;离岸贸易经营;贸易经纪;国内贸易代理;人工智能硬件销售;化工产品销售(不含许可类化工产品);3D打印基础材料销售;石墨烯材料销售;高纯元素及化合物销售;第二类医疗器械销售;第一类医疗器械销售;食用农产品批发;食品销售(仅销售预包装食品);食品互联网销售(仅销售预包装食品);农副产品销售;豆及薯类销售;谷物销售;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;生物化工产品技术研发;新材料技术研发;物联网技术研发;细胞技术研发和应用;自然科学研究和试验发展;医学研究和试验发展;农业科学研究和试验发展
    免费会员研发

    企业联系电话:020-84886379👤
    📞 广州万仟医药科技有限公司 联系方式
    联系人:朱经理/林经理
    电话:020-84886379

    邮箱:info@wqpharma.cn
    ⚠️ 声明: 咨询或交易时请注意风险评估和信息核实,百琢研不参与任何交易。

    地址:广州市番禺区节能科技园
    常规和库存产品*产品总量: 225
    广州万仟医药科技有限公司 logo
    平台资质认证✓营业执照✓
    4-(3,4-二氯苯)-3,4-二氢-2H-萘-1-酮
    4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one
    产品图片其他备注:5KG;1KG纯度99% HPLC
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis Of 4(S)-(3,4-Dichlorophenyl)-3,4-Dihydro-1(2H)-Naphthalenone By Sn2 Cuprate Displacement Of An Activated Chiral Benzylic Alcohol
    作者:George J. Quallich,Teresa M. Woodall |发布日期:1992.11
    摘要:Two Routes For The Preparation Of 4(S)-(3,4-Dichlorophenyl)-3,4-Dihydro-1(2H)-Naphthalenone Are Reported. The Most Efficient Route Generates A Chiral Benzylic Alcohol By Catalytic Asymmetric Oxazaborolidine Reduction Of A γ-Ketoester That Is Subsequently Activated And Displaced In An Sn2 Manner With A Higher Order Cuprate. Intramolecular Friedel-Crafts Cyclization Of The Resulting T-Butylester Affords

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知